Human Metabolome Technologies, Inc.

6090.T
Diagnostics & Research
2026/09/18 Updated
Market Cap: $20.9M (¥3.3B)
Stock Price: $3.88 (¥605)
Exchange Rate: 1 USD = ¥155.76

Notice on Share Buyback of Treasury Stock as Performance-Conditioned Post-Delivery Restricted Stock

Board resolution for in-kind disposal of treasury stock under a performance-conditioned post-delivery restricted stock plan for two director nominees. A total of 9,982 shares disposed at 613 yen per share. Objective: strengthen compensation policy linkage to corporate value and advance mid- to long-term performance.

Importance:
Page Updated: September 18, 2026
IR Disclosure Date: September 18, 2026

Key Figures

  • 9,982株
  • 6,118,966円
  • 613円

AI要約

Overview

At today's board meeting, as part of the performance-conditioned post-delivery restricted stock plan, it was resolved to dispose treasury stock in-kind to two targeted directors. The disposed shares are 9,982, with a total disposal amount of 6,118,966 yen, and the payment due date is October 16, 2026. The targets are two directors excluding the Audit & Supervisory Board members. The aim is to strengthen linkage between the compensation system and company performance/value of shares and to promote long-term corporate value creation and value sharing with shareholders.

Background and Outlook

Under the system, cash rights are issued in-kind to acquire shares, with the total number of shares issued determined based on period-end metrics such as net profit attributable to shareholders of the parent company, with fractional parts truncated. There are strict restrictions on transfer including lock-up periods and gratuitous acquisition provisions, and treatment during corporate restructurings; note that if conditions for payment are not met, payment will not be made.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Human Metabolomics Technologies Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →